Biomedical research in the U.S. is world-class in part because of a long-standing partnership between universities and the ...
Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
Biomedical research in the U.S. is world-class in part because of a long-standing partnership between universities and the ...